KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Reta One Labs: 22 Kovera certificates.
The lab's record shows 22 certificates printed for Reta One Labs, analysed between 10 Apr 2026 and 13 May 2026, covering 11 products. Median HPLC purity is 99.87%. Kovera graded 22 as a pass and 0 as a fail.
22
certificates
99.87%
median purity
11
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 22 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 11 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
11 AS PRINTEDRetatrutide · 6Tirzepatide · 4Tesamorelin · 3MOTS-c · 2BPC-157/TB-500 · 1CJC-1295 (No DAC)/Ipamorelin · 1GHK-Cu · 1Glow · 1Klow · 1NAD+ · 1PT-141 · 1
Every certificate
NEWEST FIRST · 22 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-F5D17E | Tirzepatide | TR300626 | 99.959% | 109.6%32.87 of 30 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-84E44E | Klow | KL800526 | 99.888% | 108.0%86.37 of 80 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4A3B51 | PT-141 | PT100526 | 99.877% | 109.7%10.97 of 10 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-EE59DB | NAD+ | NAD5000526 | 99.877% | 106.9%534.74 of 500 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E3C175 | Tesamorelin | TS100526 | 99.931% | 112.8%11.28 of 10 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C92C0E | MOTS-c | MTS400526 | 99.957% | 110.5%44.19 of 40 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B61789 | Tesamorelin | TS200526 | 99.839% | 117.3%23.47 of 20 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-DA084C | Tirzepatide | TZ300326 | 99.963% | 111.4%33.43 of 30 mg | 15 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A3E4B4 | MOTS-c | MTS100326 | 99.849% | 110.4%11.04 of 10 mg | 15 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A36A5F | Tirzepatide | TZ100326 | 99.859% | 105.2%10.52 of 10 mg | 15 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8F88BE | BPC-157/TB-500 | BT200426 | 99.653% | 111.0%22.21 of 20 mg | 15 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7FC973 | CJC-1295 (No DAC)/Ipamorelin | CJIP0326 | 99.802% | 110.8%11.08 of 10 mg | 15 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7CF218 | GHK-Cu | GK1000426 | 99.864% | 108.8%108.76 of 100 mg | 15 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5CF3DD | Tirzepatide | TZ600326 | 99.919% | 105.8%63.51 of 60 mg | 15 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-51E157 | Glow | Glow700326 | 99.753% | 106.0%74.21 of 70 mg | 15 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4A9814 | Tesamorelin | TS100326 | 99.892% | 111.3%11.13 of 10 mg | 15 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E1FE69 | Retatrutide | RT600326 | 99.856% | 105.3%63.19 of 60 mg | 13 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D6DE97 | Retatrutide | RT200326 | 99.831% | 111.4%22.28 of 20 mg | 13 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D36F55 | Retatrutide | RT500326 | 99.863% | 106.0%52.98 of 50 mg | 13 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CD3D3A | Retatrutide | RT100326 | 99.803% | 117.9%11.79 of 10 mg | 13 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C3824D | Retatrutide | RT300326 | 99.892% | 112.9%33.87 of 30 mg | 13 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1A2E79-S40 | Retatrutide | RT100326 | 99.888% | 105.2%10.52 of 10 mg | 10 Apr 2026 | PASS | Kovera ↗our verifier → |